Literature DB >> 17454450

Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia.

David B Clifford1, Mesfin T Mitike, Yared Mekonnen, Jiameng Zhang, Guta Zenebe, Zenebe Melaku, Ayele Zewde, Neway Gessesse, Dawit Wolday, Tsehaynesh Messele, Mengesha Teshome, Scott Evans.   

Abstract

Human immunodeficiency virus (HIV) has been implicated in neurological complications in developed countries. Developing countries have different viral clades and potentially different genetic and social risks for these complications. Baseline neurological performance measures associated with HIV infection have rarely been available from developing countries. The authors carried our a cross-sectional neurological evaluation of a cohort of community-dwelling treatment-naïve HIV-infected patients and similar control subjects from the same communities in Ethiopia. Blinded evaluation using standardized structured questionnaires and a neurological examination was performed by neurologists and treating physicians trained by an HIV neurology specialist. Quantitative performance measures for cognitive and motor function were employed. Data were analyzed with descriptive statistical methods, standard contingency table methods, and nonparametric methods. HIV-positive and control groups were similar by age, gender, and job site. Participants included 73 HIV-positive and 87 HIV-negative controls. Fingertapping speed in the dominant hand was more poorly performed in HIV positives than negatives (P = .01) and was significantly associated with HIV viral load levels (P = .03). Other quantitative neuropsychiatric tests including timed gait, grooved pegboard, task learning, and animal naming did not show significant differences between the two groups. The overall prevalence of central nervous system (CNS) and/or peripheral nervous system (PNS) disease did not significantly differ in the two populations. HIV patients had slowed fingertapping speed correlating with viral load. Other measures of CNS and/or peripheral nervous performance did not differ from controls. The unanticipated minor evidence of HIV-associated neurocognitive and peripheral nerve deficits in this untreated HIV-positive population invite further investigation.

Entities:  

Mesh:

Year:  2007        PMID: 17454450     DOI: 10.1080/13550280601169837

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  12 in total

1.  Response to systemic HIV viral load suppression correlates with psychomotor speed performance.

Authors:  N Sacktor; R L Skolasky; P M Tarwater; J C McArthur; O A Selnes; J Becker; B Cohen; B Visscher; E N Miller
Journal:  Neurology       Date:  2003-08-26       Impact factor: 9.910

2.  Neuropsychometric performance of asymptomatic HIV-infected subjects.

Authors:  D B Clifford; R G Jacoby; J P Miller; W R Seyfried; M Glicksman
Journal:  AIDS       Date:  1990-08       Impact factor: 4.177

3.  Neuropsychological characterization of the AIDS dementia complex: a preliminary report.

Authors:  S Tross; R W Price; B Navia; H T Thaler; J Gold; D A Hirsch; J J Sidtis
Journal:  AIDS       Date:  1988-04       Impact factor: 4.177

4.  Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex.

Authors:  F A Schmitt; J W Bigley; R McKinnis; P E Logue; R W Evans; J L Drucker
Journal:  N Engl J Med       Date:  1988-12-15       Impact factor: 91.245

5.  Identification of a genetic subcluster of HIV type 1 subtype C (C') widespread in Ethiopia.

Authors:  A Abebe; G Pollakis; A L Fontanet; B Fisseha; B Tegbaru; A Kliphuis; G Tesfaye; H Negassa; M Cornelissen; J Goudsmit; T F Rinke de Wit
Journal:  AIDS Res Hum Retroviruses       Date:  2000-11-20       Impact factor: 2.205

Review 6.  Retroviral diseases of the nervous system: pathogenic host response or viral gene-mediated neurovirulence?

Authors:  C Power
Journal:  Trends Neurosci       Date:  2001-03       Impact factor: 13.837

7.  The International HIV Dementia Scale: a new rapid screening test for HIV dementia.

Authors:  Ned C Sacktor; Matthew Wong; Noeline Nakasujja; Richard L Skolasky; Ola A Selnes; Seggane Musisi; Kevin Robertson; Justin C McArthur; Allan Ronald; Elly Katabira
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

8.  Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences.

Authors:  C Power; J C McArthur; R T Johnson; D E Griffin; J D Glass; S Perryman; B Chesebro
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Decline in prevalence of HIV-1 infection and syphilis among young women attending antenatal care clinics in Addis Ababa, Ethiopia: results from sentinel surveillance, 1995-2001.

Authors:  Aster Tsegaye; Tobias F Rinke De Wit; Yared Mekonnen; Asfaw Beyene; Mathias Aklilu; Tsehaynesh Messele; Almaz Abebe; Roel Coutinho; Eduard Sanders; Arnaud L Fontanet
Journal:  J Acquir Immune Defic Syndr       Date:  2002-07-01       Impact factor: 3.731

10.  Evaluation of the Eiken latex agglutination test for anti-Toxoplasma antibodies and seroprevalence of Toxoplasma infection among factory workers in Addis Ababa, Ethiopia.

Authors:  T Woldemichael; A L Fontanet; T Sahlu; H Gilis; T Messele; T F Rinke de Wit; H Yeneneh; R A Coutinho; T Van Gool
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Jul-Aug       Impact factor: 2.184

View more
  33 in total

1.  Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts.

Authors:  Theodore D Ruel; Michael J Boivin; Hannah E Boal; Paul Bangirana; Edwin Charlebois; Diane V Havlir; Philip J Rosenthal; Grant Dorsey; Jane Achan; Carolyne Akello; Moses R Kamya; Joseph K Wong
Journal:  Clin Infect Dis       Date:  2012-02-04       Impact factor: 9.079

Review 2.  NeuroAIDS in Africa.

Authors:  Kevin Robertson; Jeff Liner; James Hakim; Jean-Louis Sankalé; Igor Grant; Scott Letendre; David Clifford; Amadou Gallo Diop; Assan Jaye; Georgette Kanmogne; Alfred Njamnshi; T Dianne Langford; Tufa Gemechu Weyessa; Charles Wood; Mwanza Banda; Mina Hosseinipour; Ned Sacktor; Noeline Nakasuja; Paul Bangirana; Robert Paul; John Joska; Joseph Wong; Michael Boivin; Penny Holding; Betsy Kammerer; Annelies Van Rie; Prudence Ive; Avindra Nath; Kathy Lawler; Clement Adebamowo; Walter Royal; Jeymohan Joseph
Journal:  J Neurovirol       Date:  2010-05       Impact factor: 2.643

Review 3.  Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders.

Authors:  Suman Jayadev; Gwenn A Garden
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-17       Impact factor: 4.147

4.  Cognitive Impairment in Zambians With HIV Infection and Pulmonary Tuberculosis.

Authors:  Knut A Hestad; Jonathan Chinyama; Menon J Anitha; Mary S Ngoma; J Allen McCutchan; Donald R Franklin; Robert K Heaton
Journal:  J Acquir Immune Defic Syndr       Date:  2019-01-01       Impact factor: 3.731

5.  Second assessment of NeuroAIDS in Africa.

Authors:  Kevin Robertson; Kathy Kopnisky; James Hakim; Concepta Merry; Noeline Nakasujja; Colin Hall; Moussa Traore; Ned Sacktor; David Clifford; Charles Newton; Annelies Van Rie; Penny Holding; Janice Clements; Christine Zink; Jens Mielk; Mina Hosseinipour; Umesh Lalloo; Farida AMod; Christina Marra; Scott Evans; Jeff Liner
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

6.  Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia.

Authors:  Norma Kabuba; J Anitha Menon; Donald R Franklin; Robert K Heaton; Knut A Hestad
Journal:  AIDS Behav       Date:  2017-06

Review 7.  Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders.

Authors:  William Tyor; Cari Fritz-French; Avindra Nath
Journal:  J Neurovirol       Date:  2013-10-16       Impact factor: 2.643

8.  Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China.

Authors:  Robert K Heaton; Lucette A Cysique; Hua Jin; Chuan Shi; Xin Yu; Scott Letendre; Donald R Franklin; Christopher Ake; Ofilio Vigil; J Hampton Atkinson; Thomas D Marcotte; Igor Grant; Zunyou Wu
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

9.  Neuronal toxicity in HIV CNS disease.

Authors:  Jane Kovalevich; Dianne Langford
Journal:  Future Virol       Date:  2012-07-01       Impact factor: 1.831

10.  Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.

Authors:  Kathy Lawler; Mosepele Mosepele; Sarah Ratcliffe; Esther Seloilwe; Katherine Steele; Rudo Nthobatsang; Andrew Steenhoff
Journal:  J Int AIDS Soc       Date:  2010-04-20       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.